Who
Douglas J. Hughes
Director
Company insider
Files Form 4 as: Director, Immunovant; Director, Eargo.
In numbers
- Trades disclosed
- 30
- Buys
- 1
- Sells
- 3
- Bought
- $150K
- Sold
- $586K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 18 Dec 2019
- Last trade
- 7 Apr 2026
- Last filed
- 9 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Apr 2026filed 9 Apr 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Code A | —13,880 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | IMVT Immunovantoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,061 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | IMVT Immunovantoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,061 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Code A | —13,880 at $0.00 | filing |
| 1 Dec 2025filed 3 Dec 2025 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $303K13,091 at $23.14 | filing |
| 1 Dec 2025filed 3 Dec 2025 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $46K1,909 at $23.96 | filing |
| 1 Apr 2025filed 3 Apr 2025 | IMVT Immunovantoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,600 at $0.00 | filing |
| 1 Apr 2025filed 3 Apr 2025 | IMVT ImmunovantBiotechnology | SEC FORM 4 Code A | —16,188 at $0.00 | filing |
| 2 Dec 2024filed 4 Dec 2024 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $155K5,425 at $28.54 | filing |
| 2 Apr 2024filed 4 Apr 2024 | IMVT Immunovantoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,690 at $0.00 | filing |
| 2 Apr 2024filed 4 Apr 2024 | IMVT ImmunovantBiotechnology | SEC FORM 4 Code A | —11,255 at $0.00 | filing |
| 12 Apr 2023filed 14 Apr 2023 | IMVT Immunovantoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,260 at $0.00 | filing |
| 12 Apr 2023filed 14 Apr 2023 | IMVT ImmunovantBiotechnology | SEC FORM 4 Code A | —12,523 at $0.00 | filing |
| 23 Nov 2022filed 25 Nov 2022 | Eargooption or derivative | SEC FORM 4 Code X | —7,500 at $0.00 | filing |
| 22 Nov 2022filed 25 Nov 2022 | Eargo | SEC FORM 4 Code X | $36K71,363 at $0.50 | filing |
| 12 Oct 2022filed 14 Oct 2022 | Eargooption or derivative | SEC FORM 4 Code A | —74,074 at $0.00 | filing |
| 23 Aug 2022filed 25 Aug 2022 | Eargooption or derivative | SEC FORM 4 Code A | —74,805 at $0.00 | filing |
| 17 Aug 2022filed 19 Aug 2022 | IMVT Immunovantoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,668 at $0.00 | filing |
| 17 Aug 2022filed 19 Aug 2022 | IMVT ImmunovantBiotechnology | SEC FORM 4 Code A | —21,059 at $0.00 | filing |
| 10 Jan 2022filed 12 Jan 2022 | IMVT Immunovantoption or derivative · Biotechnology | SEC FORM 4 Code A | —71,492 at $0.00 | filing |
News
Immunovant (NASDAQ:IMVT) Insider Tuyl Christopher Van Sells 1,327 Shares of Company StockIMVT · themarketsdaily.com · 10 Oct 2026Immunovant (NASDAQ:IMVT) Stock: Insider Jay Stout Sells 3,809 SharesIMVT · themarketsdaily.com · 9 Oct 2026Immunovant (NASDAQ:IMVT) CEO Sells $119,589.66 in StockIMVT · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Douglas J. Hughes; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.